Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
|Articles|September 1, 2016
Controller for Stability Chamber Complies with Electronic Records Requirements
Cincinnati Sub-Zero’s stability chamber controller is validated to comply with FDA guidance for electronic records and digital signatures.
Advertisement
Cincinnati Sub-Zero’s stability chambers and stability rooms incorporate the EZT-570S controller, which is now validated to comply with the FDA 21 CFR Part 11 guidance document for electronic records and digital signatures. The stability chambers can be used for International Council for Harmonization (ICH) Q1A pharmaceutical stability testing, shelf life testing, package testing, accelerated aging, and other tests.
The touch-screen controller simplifies chamber operation using data logging, ethernet control and monitoring from any smart phone or tablet, alarm notification via email and/or text message, data file backup, full system security, audit trail, digital signatures, and power recovery options.
Source:
Advertisement
Related to this article
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Tavapadon Sets Development Benchmark for Parkinson's
2
KRAS G12D Inhibitor's $2.13B Deal Tests Cross-Border Tech Transfer
3
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
4
PharmTech’s Weekly Roundup—September 25, 2026
5